ROSUVASTATIN CALCIUM PLACEBO

OTHER2 trials

Sponsors

EMS

Conditions

DyslipidemiaDyslipidemia Associated With Type II Diabetes MellitusType 2 Diabetes Mellitus

Phase 3

Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

RecruitingNCT04602754

EMSDyslipidemia Associated With Type II Diabetes Mellitus

Start: 2023-12-01End: 2027-09-30Target: 228Updated: 2025-12-08

Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia

EMSDyslipidemia, Type 2 Diabetes Mellitus

Start: 2023-03-31End: 2025-08-31Target: 240Updated: 2022-08-05